India to Brazil: Trastuzumab Export Trade Route
India has recorded 91 verified shipments of Trastuzumab exported to Brazil, representing a combined trade value of $4.1M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $45.4K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 42% of total export value with 4 shipments worth $1.7M USD. On the buying side, LIBBS FARMACEUTICA LTDA. is the largest importer in Brazil with $1.7M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, BIOCON BIOLOGICS INDIA LIMITED, SPECIALITY MEDICINES LIMITED — together control 86% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Trastuzumab corridor is one of India's established pharmaceutical export routes, with 91 shipments documented worth a combined $4.1M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $45.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with trastuzumab's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 33.0%, placing it at rank #9 among India's top trastuzumab export destinations globally.
On the import side, key buyers of Indian trastuzumab in Brazil include LIBBS FARMACEUTICA LTDA., BIOCON BIOLOGICS UK LIMITED, TO THE ORDER OF and 16 others. LIBBS FARMACEUTICA LTDA. is the single largest importer with 4 shipments valued at $1.7M USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#9
- Annual growth+33.0%
- Demand growth+29.3%
- Regulatory ease86/100
Top 10 Indian Trastuzumab Exporters to Brazil
Showing top 10 of 10 Indian suppliers exporting Trastuzumab to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $433.9K per shipment | 4 | $1.7M | 42.0% |
| 2 | BIOCON BIOLOGICS INDIA LIMITED Avg $1.5M per shipment | 1 | $1.5M | 37.0% |
| 3 | SPECIALITY MEDICINES LIMITED Avg $10.1K per shipment | 28 | $281.9K | 6.8% |
| 4 | VAMA LIFECARE PRIVATE LIMITED Avg $7.5K per shipment | 28 | $211.0K | 5.1% |
| 5 | SPECIALITY MEDICINES PRIVATE LIMITED Avg $11.8K per shipment | 14 | $165.5K | 4.0% |
| 6 | NIVIRA EXPORTS Avg $20.1K per shipment | 6 | $120.6K | 2.9% |
| 7 | TIMES MEDICAMENT PRIVATE LIMITED Avg $13.9K per shipment | 5 | $69.5K | 1.7% |
| 8 | CORSANTRUM TECHNOLOGY Avg $4.9K per shipment | 2 | $9.7K | 0.2% |
| 9 | YARAPMIN PHARMA PRIVATE LIMITED Avg $3.8K per shipment | 2 | $7.6K | 0.2% |
| 10 | ALLEVIARE LIFE SCIENCES PRIVATE LIMITED Avg $3.1K per shipment | 1 | $3.1K | 0.1% |
This table shows the top 10 of 10 Indian companies exporting trastuzumab to Brazil, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, BIOCON BIOLOGICS INDIA LIMITED, SPECIALITY MEDICINES LIMITED, VAMA LIFECARE PRIVATE LIMITED, SPECIALITY MEDICINES PRIVATE LIMITED, NIVIRA EXPORTS, TIMES MEDICAMENT PRIVATE LIMITED, CORSANTRUM TECHNOLOGY, YARAPMIN PHARMA PRIVATE LIMITED, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED. MYLAN LABORATORIES LIMITED is the dominant supplier with 4 shipments worth $1.7M USD, giving it a 42% market share. The top 3 suppliers together account for 86% of the total trade value on this route.
Top 10 Trastuzumab Importers in Brazil
Showing top 10 of 19 known buyers in Brazil receiving Trastuzumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian trastuzumab in Brazil include LIBBS FARMACEUTICA LTDA., BIOCON BIOLOGICS UK LIMITED, TO THE ORDER OF, AS PER INVOICE BRAZIL, `TO THE ORDER OF, among 19 total buyers. The largest importer is LIBBS FARMACEUTICA LTDA., accounting for $1.7M USD across 4 shipments — representing 42% of all trastuzumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LIBBS FARMACEUTICA LTDA. | 4 | $1.7M | 42.0% |
| 2 | BIOCON BIOLOGICS UK LIMITED | 1 | $1.5M | 37.0% |
| 3 | TO THE ORDER OF | 29 | $329.2K | 8.0% |
| 4 | AS PER INVOICE BRAZIL | 24 | $173.9K | 4.2% |
| 5 | `TO THE ORDER OF | 10 | $92.2K | 2.2% |
| 6 | JACQUELINE FERREIRA DE SOUZA LOPES | 2 | $54.6K | 1.3% |
| 7 | TO THE ORDER | 4 | $38.5K | 0.9% |
| 8 | TO THE ORDER OF, | 2 | $34.0K | 0.8% |
| 9 | AS PER INVOICE | 3 | $32.9K | 0.8% |
| 10 | SANDRA OLIVEIRA SANTOS | 1 | $28.5K | 0.7% |
Showing top 10 of 19 Trastuzumab importers in Brazil on this route.
Top 10 Trastuzumab Formulations Imported by Brazil
Showing top 10 of 53 product formulations shipped on the India to Brazil Trastuzumab route, ranked by trade value
Brazil imports a wide range of trastuzumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ZEDORA 440MG -TRASTUZUMAB FOR — accounts for $1.5M USD across 1 shipments. There are 53 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZEDORA 440MG -TRASTUZUMAB FOR | 1 | $1.5M | 37.0% |
| 2 | TRASTUZUMAB LYOPHILIZED POWDER FOR INJECTION (R-DNA ORIGIN) 440MG/VIAL. BATCH NO. 7802489 | 2 | $868.6K | 21.0% |
| 3 | TRASTUZUMAB LYOPHILIZED POWDER FOR INJECTION (R-DNA ORIGIN) 440MG/VIAL. BATCH NO. 7802490 | 2 | $867.2K | 21.0% |
| 4 | HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE TRASTUZUMAB DERUSTECAN 100MG INJECTION | 4 | $85.0K | 2.1% |
| 5 | HARMLESS PHARMACEUTICAL MEDICINE GOING FOR HUMAN CONSUMPTION: TRASTUZUMAB DERUXTECAN 100MG PER VIAL (ENHERTU) | 4 | $70.9K | 1.7% |
| 6 | HARMLESS MEDICINE FOR HUMAN CONSUMPTION TRASTUZUMAB DERUXTECAN 100 MG PER VIAL BATCH NUMBER.: 418342 MANUFACT | 7 | $60.2K | 1.5% |
| 7 | HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE - TRASTUZUMAB DERUXTECAN INJECTION | 5 | $46.2K | 1.1% |
| 8 | HARMLESS MEDICINE FOR HUMAN CONSUMPTION INJ. TRASTUZUMAB DERUXTECAN 100 MG BATCH NUMBER.: 418342 MANUFACTURIN | 6 | $42.2K | 1.0% |
| 9 | HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE: TRASTUZUMAB DERUSTECAN 100MG INJECTION | 6 | $41.8K | 1.0% |
| 10 | HARMLESS PHARMACEUTICAL MEDICINE FOR HUMAN USE BATCH NO 422897 TRASTUZUMAB DERUXTECAN INJECTION | 1 | $38.8K | 0.9% |
Showing top 10 of 53 Trastuzumab formulations imported by Brazil on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 32 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's trastuzumab exports to Brazil are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, BIOCON BIOLOGICS INDIA LIMITED, SPECIALITY MEDICINES LIMITED — together account for 86% of total trade value on this route. The average shipment value of $45.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as trastuzumab lyophilized powder for injection (r-dna origin) 440mg/vial. batch no. 7802489 and trastuzumab lyophilized powder for injection (r-dna origin) 440mg/vial. batch no. 7802490, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LIBBS FARMACEUTICA LTDA. is the largest importer with 4 shipments worth $1.7M USD — representing 42% of all trastuzumab imports from India on this route. A total of 19 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.1M
- Avg. Shipment
- $45.4K
- Suppliers
- 10
- Buyers
- 19
- Transit (Sea)
- ~31 days
- Annual Growth
- +33.0%
Related Analysis
Other Trastuzumab Routes
Unlock the Full India to Brazil Trastuzumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 91 shipments on this route.
Frequently Asked Questions — India to Brazil Trastuzumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Trastuzumab to Brazil?
The leading Indian exporters of Trastuzumab to Brazil are MYLAN LABORATORIES LIMITED, BIOCON BIOLOGICS INDIA LIMITED, SPECIALITY MEDICINES LIMITED. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 42% of total trade value on this route.
Q What is the total value of Trastuzumab exports from India to Brazil?
India exports Trastuzumab to Brazil worth approximately $4.1M USD across 91 recorded shipments. The average value per shipment is $45.4K USD.
Q Which ports does India use to ship Trastuzumab to Brazil?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 32 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Brazil for Trastuzumab?
The average transit time for Trastuzumab shipments from India to Brazil is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Brazil Trastuzumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 33.0% with demand growth tracking at 29.3%. The route is ranked #9 among India's top Trastuzumab export destinations globally.
Q How many suppliers are active on the India to Brazil Trastuzumab route?
There are currently 10 active Indian suppliers exporting Trastuzumab to Brazil. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 42% of total shipment value.
Q Who are the main importers of Trastuzumab from India in Brazil?
The leading importers of Indian Trastuzumab in Brazil include LIBBS FARMACEUTICA LTDA., BIOCON BIOLOGICS UK LIMITED, TO THE ORDER OF, AS PER INVOICE BRAZIL, `TO THE ORDER OF. LIBBS FARMACEUTICA LTDA. is the largest buyer with 4 shipments worth $1.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Trastuzumab.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 19 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 91 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
91 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists